https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

IDIVAL, the Government of Cantabria and Farmaindustria bring knowledge about biomedical research to high school students

5 de March de 2024

One hundred students from four schools and high schools in Cantabria learn about the role of hospitals and the pharmaceutical industry in the development of a drug or how a patient can participate in a clinical trial. Bringing science closer to schools, the program promoted by Farmaindustria in collaboration with research centers since 2016 has […]

Read more →

IDIVAL and HUMV organize a course on Generative Artificial Intelligence in basic and/or clinical research

4 de March de 2024

Registrations are open for the seminar that will delve into the types, uses and ethical issues of generative artificial intelligence. Next Monday March 11 will be held the training course called ‘How to improve your workflows with generative AI in basic and/or clinical research’ which will take place in the afternoon (16h to 20h) in […]

Read more →

IDIVAL leads the health research sub-module in the Master in Health Services Management of the UC

16 de February de 2024

Clinical trials, industrial property or human factor engineering will be key topics to be discussed with the students. The Valdecilla Health Research Institute (IDIVAL) participates in the Master’s Degree in Health Services Management of the University of Cantabria (UC), whose objective is to train professionals capable of leading processes of change and innovation in health […]

Read more →

IDIVAL researchers organize a conference on the occasion of World Day for Rare Diseases

13 de February de 2024

On the occasion of the World Day for Rare Diseases on February 29th, the Valdecilla Institute for Health Research (IDIVAL) will hold an event entitled ‘Update day on Rare Diseases and the need for a multiprofessional approach (360)´. It will be a day where they will talk about rare diseases nowadays, the different treatments available […]

Read more →

The Group of Neurodegenerative Diseases at IDIVAL reveals factors that may influence early diagnosis of Alzheimer’s disease

8 de February de 2024

Previous hypertension, diabetes and renal insufficiency could alter plasma markers A multidisciplinary research team belonging to the Neurodegenerative Diseases Group of IDIVAL and the Cognitive Impairment Unit of the Neurology Service of the Marqués de Valdecilla University Hospital (HUMV) has conducted a study aimed at understanding how different physiological variables and previous diseases could influence […]

Read more →

International visibility of IDIVAL researchers

3 de January de 2024

portal point to a high visibility of IDIVAL authors with more than 62,000 citations of articles published in the period 2018-2022. In this way, the Valdecilla brand exceeds 280,000 citations since its creation. Of note in the period 2018-22 are the citations of papers published in the areas of Immunology (1,383 citations), Pharmacology (1,307 citations) […]

Read more →

IDIVAL participates in an international project on public health

10 de August de 2023

It will allow Cantabria to implement pilot initiatives to promote healthier environments and reduce social inequalities   The EU recently approved a proposal for a Joint Action for the prevention of Cancer and other Non Communicable Diseases (NCDs) with an amount of 75 million euros, which makes it a landmark initiative in public health. A […]

Read more →

The IDIVAL Surgical Innovation and Research Group, leader in robotic colorectal surgery research at European level

1 de August de 2023

The results of the largest European prospective multicenter study on the surgical treatment of right colon cancer have been published.   The MIRCAST study, an International multicenter project led for the whole of Europe from the IDIVAL Institute, was born in 2018 with the aim of evaluating the different ways of performing intestinal anastomosis after […]

Read more →

The call for FORTALECE and Platforms of the Instituto de Salud Carlos III is open until September 12

Each call has a budget of 30 million euros to finance health research and innovation projects   On July 27th, the ISCIII opened the FORTALECE call for Health Research Institutes and the ISCIII Platforms call for support for R&D&I in Biomedicine and Health Sciences. Each call has a funding of 30 million €.   FORTALECE […]

Read more →

A study shows that patients with bimalleolar ankle fractures do not show full recovery at 12 months

20 de July de 2023

Ankle fractures are the third most frequent cause of total fractures and generate functional alterations in the short and long term.   Ankle fractures are the third most frequent cause of fractures in all ages. Surgical treatment and the period of immobilization generate important functional alterations in the short and long term such as pain, […]

Read more →